Clinical Trials Directory

Trials / Completed

CompletedNCT00659919

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
13 (actual)
Sponsor
BeerYaakov Mental Health Center · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Administration of trazodone for the treatment of neuroleptic induced acute akathisia in a cross-over fashion of 6 days duration. 3 days of placebo and 3 days of trazodone.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo
DRUGTrazodone

Timeline

Start date
2000-11-01
Primary completion
2003-12-01
Completion
2003-12-01
First posted
2008-04-17
Last updated
2008-06-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00659919. Inclusion in this directory is not an endorsement.

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone (NCT00659919) · Clinical Trials Directory